miércoles, 23 de abril de 2025

Neoantigen-Specific TILs Plus Pembrolizumab Show Promise in GI Cancers Will Pass April 22, 2025

https://www.medscape.com/viewarticle/neoantigen-specific-tils-plus-pembrolizumab-show-promise-gi-2025a10009n5

No hay comentarios:

Publicar un comentario